Latest Enbrel news
Infection Risk Lower for Etanercept Vs Monoclonal Ab Rx
by modernClinician Editorial Team
For patients with rheumatoid arthritis, etanercept is associated with lower risk for general infections and tuberculosis compared with monoclonal antibody treatment, according to a meta-analysis published online Feb. 3 in the International Journal of Rheumatic Diseases.
Study Compares Effectiveness of Biologics in Psoriasis Treatment
by modernClinician Editorial Team
For patients with psoriasis, ustekinumab has the highest effectiveness over five years of treatment and adalimumab and ustekinumab more often reach a 75 percent reduction in Psoriasis Area Severity Index compared to baseline than etanercept, according to a study published online Aug. 31 in the British Journal of Dermatology.
FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis
by modernClinician Editorial Team
A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.
Editor's Recommendations
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
Withdrawal From Medetomidine Increasingly Seen in ICUs .jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
